BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome.
作者信息
Visentin Andrea, Imbergamo Silvia, Scomazzon Edoardo, Pravato Stefano, Frezzato Federica, Bonaldi Laura, Pizzi Marco, Vio Stefania, Gregianin Michele, Burei Marta, Facco Monica, Semenzato Gianpietro, Piazza Francesco, Trentin Livio
机构信息
Haematology and Clinical Immunology Unit, Department of Medicine, University of Padua, Padua, Italy.
Venetian Institute of Molecular Medicine, Centro di Eccellenza per la Ricerca Biomedica Avanzata, Padua, Italy.
出版信息
Br J Haematol. 2019 Apr;185(1):193-197. doi: 10.1111/bjh.15440. Epub 2018 Jul 5.
PMID:29974955
Abstract
摘要
Zotero 插件